juniper networks posts

Feed

Earnings highlights: Apple (AAPL), Merrill Lynch (MER), UAL (UAUA), and many others

The earnings crunch continues to roll along, and here are a some highlights of this past week's earnings coverage from BloggingStocks:

Continue reading Earnings highlights: Apple (AAPL), Merrill Lynch (MER), UAL (UAUA), and many others

Juniper Networks' earnings not good enough

JNPR logoJuniper Networks, Inc. (NASDAQ: JNPR) is sinking after the company's earnings release yesterday evening. JNPR reported a 46% jump in quarterly profit, but only beat EPS estimates by a penny, far less than what many optimistic investors, who drove the stock up 3.5% yesterday prior to the earnings release, had expected. A Morgan Keegan analyst cautioned that Q3 expenses grew too much, and there is some worry that the company's expenses aren't under sufficient control. If you think this stock won't be rising too far in the coming months, then it could be a good time to look at a bearish hedged play on JNPR.

The stock has climbed steadily over the past seven months, reaching a 52-week high of $37.95 earlier this month. This morning, JNPR opened at $35.17. So far today the stock has hit a low of $33.43 and a high of $35.17. As of 10:40, JNPR is trading at $33.95, down $3.19 (-8.6%). The chart for JNPR looks bullish but deteriorating, while S&P gives the stock a neutral 3 STARS (out of 5) hold rating.

For a bearish hedged play on this stock, I would consider a December bear-call credit spread above the $40 range. A bear-call credit spread is an options position that combines the purchase and sale of call options to hedge risk in case the stock doesn't do what you think but still leverage nice returns. For this particular trade, we will make an 8.7% return in two months as long as JNPR is below $40 at December expiration. Juniper would have to rise by more than 17% before we would start to lose money. Learn more about this type of trade here.

Continue reading Juniper Networks' earnings not good enough

Juniper Networks: Specialists in computer network infrastructures

Whether it's over the Internet, or through the office network, getting the right computer signal to the right place is a matter most of us liken to magic. One of the world's best known performers of such legerdemain is headquartered in Sunnyvale, California.

Juniper Networks (NASDAQ: JNPR) is engaged in the design, development and sale of Internet Protocol routers. These enable service providers and other network-intensive businesses to support and deliver services and applications on an integrated network. Other offerings include network traffic management software, virtual private network appliances, application acceleration platforms and firewall devices. Customers include wireline, wireless, and cable operators; Internet content providers; general businesses; and public agencies. McDonald's (NYSE: MCD) and Dow Chemical (NYSE: DOW) are among the firm's enterprise customers. Alcatel-Lucent (NYSE: ALU), Cisco Systems (NASDAQ: CSCO) and Nortel Networks (NYSE: NT) are competitors.

The company pleased investors last week, when it reported Q2 EPS of 20 cents and revenues of $664.9 million. Analysts had been expecting 20 cents and $649.5 million. Management also guided Q3 EPS to 21 cents (21 cent consensus), Q3 revenues to $695-715 million ($674.56M consensus), FY07 EPS to 82-83 cents (81 cent consensus) and FY07 revenues to $2.73-$2.76 billion ($2.67B consensus).

Continue reading Juniper Networks: Specialists in computer network infrastructures

Analyst downgrades: 12-20: Kohl's downgraded to Neutral

MOST NOTEWORTHY: Kohl's (NYSE:KSS) and Juniper Networks (NASDAQ:JNPR) were today's most notable downgrades:
  • Kohl's was downgraded to Neutral from Outperform at Robert W Baird due to difficult comps, less benefit from key 2006 drivers and warmer weather.
  • Juniper Networks was downgraded to Sector Performer from Sector Outperformer at CIBC World Markets as there is limited share upside due to competition from the Redback Networks (NASDAQ:RBAK) /Ericsson (NASDAQ:ERIC) combination and a reduced possibility of an acquisition premium.
OTHER DOWNGRADES:
  • Panacos Pharmaceuticals (NASDAQ:PANC) was downgraded at Bear Stearns, Think Equities, RBC Capital Markets, Leerink Swann and Caris & Co. after the company released disappointing Phase II Bevirmat data.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

< Previous Page

Symbol Lookup
IndexesChangePrice
DJIA-74.9212,454.83
NASDAQ-1.852,837.53
S&P 500-2.861,317.82

Last updated: May 28, 2012: 05:00 PM

Hot Stocks

General Electric

19.20-0.05(-0.26)

Alcoa

8.630.00(0.00)

Apple Inc

562.29-3.03(-0.54)

Google Inc 'A'

591.53-12.13(-2.01)

Bank of America

7.15+0.01(+0.14)

Wal-Mart Stores

65.31+0.24(+0.37)

Exxon Mobil Corp

82.08-0.53(-0.64)

Ford

10.60+0.01(+0.09)

Citigroup

26.47-0.19(-0.71)

IBM

194.30-1.79(-0.91)

Yahoo

15.36+0.01(+0.07)

Starbucks

54.56-0.20(-0.37)

Microsoft

29.06-0.01(-0.03)

Home Depot

49.44-0.27(-0.54)

DailyFinance Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

Page Loaded in 1338238859853 ms.